Verition Fund Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31M | Buy |
438,746
+385,227
| +720% | +$20.8M | 0.16% | 131 |
|
|
2026
Q1 | $2.8M | Sell |
53,519
-41,523
| -44% | -$2.49M | 0.02% | 850 |
|
|
2025
Q4 | $5.59M | Buy |
95,042
+40,483
| +74% | +$2.46M | 0.02% | 790 |
|
|
2025
Q3 | $3.04M | Buy |
54,559
+11,527
| +27% | +$617K | 0.01% | 1627 |
|
|
2025
Q2 | $2.21M | Buy |
43,032
+13,630
| +46% | +$685K | 0.01% | 1855 |
|
|
2025
Q1 | $1.72M | Buy |
29,402
+19,825
| +207% | +$1.34M | 0.01% | 1680 |
|
|
2024
Q4 | $690K | Buy |
9,577
+365
| +4% | +$26.8K | ﹤0.01% | 2276 |
|
|
2024
Q3 | $736K | Sell |
9,212
-358
| -4% | -$26.9K | ﹤0.01% | 2089 |
|
|
2024
Q2 | $686K | Sell |
9,570
-316
| -3% | -$23.3K | ﹤0.01% | 1882 |
|
|
2024
Q1 | $696K | Buy |
9,886
+77
| +0.8% | +$5.51K | ﹤0.01% | 1826 |
|
|
2023
Q4 | $757K | Sell |
9,809
-7,021
| -42% | -$462K | 0.01% | 1304 |
|
|
2023
Q3 | $1.15M | Buy |
16,830
+7,016
| +71% | +$554K | 0.01% | 1018 |
|
|
2023
Q2 | $801K | Sell |
9,814
-1,384
| -12% | -$111K | 0.01% | 1006 |
|
|
2023
Q1 | $831K | Buy |
11,198
+7,390
| +194% | +$570K | 0.01% | 1026 |
|
|
2022
Q4 | $316K | Sell |
3,808
-248
| -6% | -$19.7K | ﹤0.01% | 1476 |
|
|
2022
Q3 | $288K | Buy |
+4,056
| New | +$350K | ﹤0.01% | 2249 |
|
|
2021
Q3 | – | Sell |
-4,616
| Closed | -$520K | – | 2298 |
|
|
2021
Q2 | $520K | Buy |
+4,616
| New | +$486K | ﹤0.01% | 1072 |
|
|
2019
Q3 | – | Sell |
-15,292
| Closed | -$797K | – | 1322 |
|
|
2019
Q2 | $797K | Sell |
15,292
-13,520
| -47% | -$681K | 0.02% | 516 |
|
|
2019
Q1 | $1.43M | Buy |
+28,812
| New | +$1.3M | 0.06% | 297 |
|
|
2018
Q4 | – | Sell |
-12,772
| Closed | -$652K | – | 1244 |
|
|
2018
Q3 | $652K | Buy |
12,772
+4,336
| +51% | +$192K | 0.02% | 736 |
|
|
2018
Q2 | $312K | Buy |
+8,436
| New | +$322K | 0.02% | 841 |
|
|
2017
Q4 | – | Sell |
-20,516
| Closed | -$620K | – | 1223 |
|
|
2017
Q3 | $620K | Buy |
+20,516
| New | +$609K | 0.05% | 478 |
|
|
2017
Q2 | – | Sell |
-34,400
| Closed | -$874K | – | 1284 |
|
|
2017
Q1 | $874K | Buy |
+34,400
| New | +$888K | 0.08% | 308 |
|
|
2016
Q2 | – | Sell |
-21,448
| Closed | -$507K | – | 1047 |
|
|
2016
Q1 | $507K | Buy |
+21,448
| New | +$472K | 0.08% | 310 |
|
|
2015
Q4 | – | Sell |
-23,056
| Closed | -$533K | – | 598 |
|
|
2015
Q3 | $533K | Buy |
+23,056
| New | +$578K | 0.14% | 190 |
|
|
2015
Q2 | – | Sell |
-46,068
| Closed | -$1.16M | – | 712 |
|
|
2015
Q1 | $1.16M | Buy |
+46,068
| New | +$1.1M | 0.13% | 49 |
|
Other funds holding TECH
HI
Verition Fund Management's TECH Position: Q2 2026 in Review
Verition Fund Management increased its Bio-Techne (TECH) stake by 720% in Q2 2026, buying an estimated $20.8M and bringing the position to 438,746 shares worth $31M. The position accounts for 0.16% of the portfolio, ranked #131.
Verition Fund Management first reported a position in TECH in Q1 2015 and has held it in 26 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Verition Fund Management held 438,746 shares of Bio-Techne worth $31M as of Q2 2026.
- Verition Fund Management bought 385,227 Bio-Techne shares in Q2 2026, an estimated $20.8M.
- Bio-Techne made up 0.16% of Verition Fund Management's portfolio in Q2 2026, its #131 holding.
- Verition Fund Management first reported a position in Bio-Techne in Q1 2015 and has held it in 26 quarters since.
- 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.